Somerset, NJ, United States of America

Curtis Karl

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Becton Dickinson and Company Limited. Active years: 2002.


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Curtis Karl: Innovator in Transdermal Drug Delivery Systems

Introduction

Curtis Karl is a notable inventor based in Somerset, NJ (US), recognized for his contributions to the field of transdermal drug delivery systems. With a focus on innovative solutions, he has developed a unique approach to medicament-loaded transdermal reservoirs.

Latest Patents

Curtis Karl holds a patent for a "Medicament-loaded transdermal reservoir and method for its formation." This invention involves a transdermal reservoir that utilizes a bibulous reservoir blocking a backing. The design includes an interior surface with a patient contact surface shaped to enhance the delivery of medication. The method allows for the loading of a material into the reservoir through a closure that forms a releasable seal, ensuring the integrity of the medicament until it is needed.

Career Highlights

Curtis Karl is currently employed at Becton Dickinson and Company Limited, where he continues to innovate in the medical technology sector. His work focuses on improving drug delivery methods, which can significantly enhance patient care and treatment outcomes.

Collaborations

Some of his notable coworkers include Michael I Bernhard and Gary Kupperblatt, who contribute to the collaborative environment that fosters innovation at Becton Dickinson.

Conclusion

Curtis Karl's work in developing transdermal drug delivery systems exemplifies the impact of innovation in healthcare. His patent and ongoing contributions highlight the importance of advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…